Pharmacokinetics and pharmacodynamics of intravenous artesunate in severe falciparum malaria.
about
Review of the clinical pharmacokinetics of artesunate and its active metabolite dihydroartemisinin following intravenous, intramuscular, oral or rectal administrationOral bioavailability of dihydroartemisinin in Vietnamese volunteers and in patients with falciparum malariaPopulation pharmacokinetics of intravenous artesunate: a pooled analysis of individual data from patients with severe malaria.Impaired nitric oxide bioavailability and L-arginine reversible endothelial dysfunction in adults with falciparum malaria.Recovery of endothelial function in severe falciparum malaria: relationship with improvement in plasma L-arginine and blood lactate concentrations.Pharmacokinetic evaluation of intravenous artesunate in adults with uncomplicated falciparum malaria in Kenya: a phase II study.Intravenous artesunate for the treatment of severe malaria.Intramuscular bioavailability and clinical efficacy of artesunate in gabonese children with severe malaria.Interspecies allometric scaling of antimalarial drugs and potential application to pediatric dosing.Penetration of dihydroartemisinin into cerebrospinal fluid after administration of intravenous artesunate in severe falciparum malaria.Artemisinins.The pharmacokinetic properties of intramuscular artesunate and rectal dihydroartemisinin in uncomplicated falciparum malariaProtein binding and alpha : beta anomer ratio of dihydroartemisinin in vivoUltrastructural and real-time microscopic changes in P. falciparum-infected red blood cells following treatment with antimalarial drugs.Pharmacokinetic profiles of artesunate following multiple intravenous doses of 2, 4, and 8 mg/kg in healthy volunteers: phase 1b studyPharmacokinetics and pharmacodynamics of intravenous artesunate during severe malaria treatment in Ugandan adults.Disposition of artesunate and dihydroartemisinin after administration of artesunate suppositories in children from Papua New Guinea with uncomplicated malaria.Artesunate, artemether or quinine in severe Plasmodium falciparum malaria?Population pharmacokinetics of intramuscular artesunate in African children with severe malaria: implications for a practical dosing regimen.The role of red blood cell exchange for severe imported malaria in the artesunate era: a retrospective cohort study in a referral centreAngiopoietin-2 is associated with decreased endothelial nitric oxide and poor clinical outcome in severe falciparum malaria.Comparative pharmacokinetics and pharmacodynamics of intravenous artelinate versus artesunate in uncomplicated Plasmodium coatneyi-infected rhesus monkey modelComparative pharmacokinetics of intramuscular artesunate and artemether in patients with severe falciparum malaria.Use of quantitative pharmacology tools to improve malaria treatments.Targeting nasopharyngeal carcinoma by artesunate through inhibiting Akt/mTOR and inducing oxidative stress.Lymphoma and myeloma cells are highly sensitive to growth arrest and apoptosis induced by artesunate.Comparative study of the effects of artemether and artesunate on juvenile and adult Schistosoma mansoni in experimentally infected mice.Artemisia annua dried leaf tablets treated malaria resistant to ACT and i.v. artesunate: Case reports.Design of a new line in treatment of experimental rheumatoid arthritis by artesunate.Assessment of the effect of mefloquine on artesunate pharmacokinetics in healthy male volunteers.Stability and antiviral activity against human cytomegalovirus of artemisinin derivatives.Toxicokinetics and hydrolysis of artelinate and artesunate in malaria-infected rats.Bioequivalence of Two Intravenous Artesunate Products with Its Active Metabolite Following Single and Multiple Injections.Artesunate shows potent anti-tumor activity in B-cell lymphoma.Comparison of the Pharmacokinetics and Ex Vivo Antimalarial Activities of Artesunate-Amodiaquine and Artemisinin-Piperaquine in Healthy Volunteers for Preselection Malaria Therapy.Induction of Apoptosis in Human Breast Cancer MCF-7 Cells by a Semi-Synthetic Derivative of Artemisinin: A Caspase-Related Mechanism.2D Inorganic-Antimalarial Drug-Polymer Hybrid with pH-Responsive Solubility
P2860
Q21034080-B4FA6872-5097-4F7B-A20F-37D5D233048AQ28367549-59A85195-9B2A-4096-98CB-226B19D0DF9FQ30867699-B1A19398-AA8A-4F03-81FE-3CD7EB975DB4Q33303521-8887BDE9-CD28-4A6B-8104-710704DC9E49Q33349599-9F149316-DA42-4769-AE85-BFF9933FB13BQ33958541-70CBA3BF-85B6-49D6-893D-D27921968B4AQ34120984-E093E8E7-32E6-4472-AE35-533C9CA1BE8BQ34252476-836E92E3-58D8-4FDA-AE6A-ABAB4183A1B9Q34299078-20F69888-01EB-4395-8312-754564C1B2AFQ34719976-BEC44CD9-A2EE-42A1-9B4A-602CC40DEAF1Q35521094-25AAE00E-D32C-4505-BD4B-CAD5E8DC9951Q35804378-953F4EE8-1792-46C5-B8CF-54040532A71BQ35826018-65BAB5E1-61CF-467B-A918-C1336DF004B3Q36240246-BFE371E3-A6A1-4CB6-8951-17CA48B0A1C4Q36309099-226A2916-7A06-43F3-94E3-5CFD694CAD7CQ36372854-2EA681CB-8E6D-457D-8CA1-94441BC92742Q36669256-6815830C-F406-45FB-AFF7-1EDA945AD09CQ36777830-C5D1DB07-3B6A-4F5A-8FE6-9A9F78618A34Q36778732-E8ABC7B4-1AEA-4F99-B94F-C521A45B0C46Q36796904-94CDF75D-B7ED-4813-8ED9-0E764612FC5DQ36954307-DEB8145A-6EC3-499E-9848-2578B0CAC6D7Q37233295-CA3B0A71-3A29-4A15-A5C8-38C49D7A5FDAQ37598749-F06B25EE-FA16-4615-B070-3026F53E9498Q38664529-E0C2CF3B-7096-461E-9C3D-3EE718DF799BQ39025516-53836EE5-5BB1-4524-ACDA-59F3B5EF95BDQ39123470-05023CE8-FE5F-4050-8444-91A3F0AAD8B1Q39544928-79C79537-F1E2-4E4D-ABF0-868593FEECA0Q40046867-DA655156-2DDE-4BBA-9210-30AAC23EE3D8Q40228242-741D2706-2558-4794-976D-D77B60FF0FCCQ42137131-F47D5A94-44A7-44C0-96AC-5E375A076F88Q42272265-316DDAFB-7263-408A-BE48-5D632D097E2EQ46673461-5E17B579-B103-45E4-ADF7-39A1B3C588D5Q46713477-5800E2CB-31B6-4C2E-AB2B-E6EE20D183C3Q49843417-6D7CE1CB-6F7F-489C-9316-F0CEE800FCD6Q53685504-D25403B1-F284-4E7C-8604-BB80C715ED69Q54994204-F2910EB5-157F-499C-98DA-469E0FAB7EDFQ57765495-47DFF2DC-78AB-4585-90DD-CE19A54E0344
P2860
Pharmacokinetics and pharmacodynamics of intravenous artesunate in severe falciparum malaria.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Pharmacokinetics and pharmacod ...... in severe falciparum malaria.
@ast
Pharmacokinetics and pharmacod ...... in severe falciparum malaria.
@en
type
label
Pharmacokinetics and pharmacod ...... in severe falciparum malaria.
@ast
Pharmacokinetics and pharmacod ...... in severe falciparum malaria.
@en
prefLabel
Pharmacokinetics and pharmacod ...... in severe falciparum malaria.
@ast
Pharmacokinetics and pharmacod ...... in severe falciparum malaria.
@en
P2093
P2860
P921
P1476
Pharmacokinetics and pharmacod ...... e in severe falciparum malaria
@en
P2093
H L Phuong
S M Powell
V D Phuong
P2860
P304
P356
10.1128/AAC.45.1.181-186.2001
P407
P577
2001-01-01T00:00:00Z